Cargando…
How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations?
While epidemiological and economic evidence has the potential to provide answers to questions, guide complex programmes and inform resource allocation decisions, how this evidence is used by global health organisations who commission it and what organisational actions are generated from the evidence...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422320/ https://www.ncbi.nlm.nih.gov/pubmed/34489331 http://dx.doi.org/10.1136/bmjgh-2021-006827 |
_version_ | 1783749262329249792 |
---|---|
author | Christen, Paula Conteh, Lesong |
author_facet | Christen, Paula Conteh, Lesong |
author_sort | Christen, Paula |
collection | PubMed |
description | While epidemiological and economic evidence has the potential to provide answers to questions, guide complex programmes and inform resource allocation decisions, how this evidence is used by global health organisations who commission it and what organisational actions are generated from the evidence remains unclear. This study applies analytical tools from organisational science to understand how evidence produced by infectious disease epidemiologists and health economists is used by global health organisations. A conceptual framework that embraces evidence use typologies and relates findings to the organisational process of action generation informs and structures the research. Between March and September 2020, we conducted in-depth interviews with mathematical modellers (evidence producers) and employees at global health organisations, who are involved in decision-making processes (evidence consumers). We found that commissioned epidemiological and economic evidence is used to track progress and provides a measure of success, both in terms of health outcomes and the organisations’ mission. Global health organisations predominantly use this evidence to demonstrate accountability and solicit funding from external partners. We find common understanding and awareness across consumers and producers about the purposes and uses of these commissioned pieces of work and how they are distinct from more academic explorative research outputs. Conceptual evidence use best describes this process. Evidence is slowly integrated into organisational processes and is one of many influences on global health organisations’ actions. Relationships developed over time and trust guide the process, which may lead to quite a concentrated cluster of those producing and commissioning models. These findings raise several insights relevant to the literature of research utilisation in organisations and evidence-based management. The study extends our understanding of how evidence is used and which organisational actions are generated as a result of commissioning epidemiological and economic evidence. |
format | Online Article Text |
id | pubmed-8422320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-84223202021-09-22 How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? Christen, Paula Conteh, Lesong BMJ Glob Health Original Research While epidemiological and economic evidence has the potential to provide answers to questions, guide complex programmes and inform resource allocation decisions, how this evidence is used by global health organisations who commission it and what organisational actions are generated from the evidence remains unclear. This study applies analytical tools from organisational science to understand how evidence produced by infectious disease epidemiologists and health economists is used by global health organisations. A conceptual framework that embraces evidence use typologies and relates findings to the organisational process of action generation informs and structures the research. Between March and September 2020, we conducted in-depth interviews with mathematical modellers (evidence producers) and employees at global health organisations, who are involved in decision-making processes (evidence consumers). We found that commissioned epidemiological and economic evidence is used to track progress and provides a measure of success, both in terms of health outcomes and the organisations’ mission. Global health organisations predominantly use this evidence to demonstrate accountability and solicit funding from external partners. We find common understanding and awareness across consumers and producers about the purposes and uses of these commissioned pieces of work and how they are distinct from more academic explorative research outputs. Conceptual evidence use best describes this process. Evidence is slowly integrated into organisational processes and is one of many influences on global health organisations’ actions. Relationships developed over time and trust guide the process, which may lead to quite a concentrated cluster of those producing and commissioning models. These findings raise several insights relevant to the literature of research utilisation in organisations and evidence-based management. The study extends our understanding of how evidence is used and which organisational actions are generated as a result of commissioning epidemiological and economic evidence. BMJ Publishing Group 2021-09-06 /pmc/articles/PMC8422320/ /pubmed/34489331 http://dx.doi.org/10.1136/bmjgh-2021-006827 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Christen, Paula Conteh, Lesong How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? |
title | How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? |
title_full | How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? |
title_fullStr | How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? |
title_full_unstemmed | How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? |
title_short | How are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? |
title_sort | how are mathematical models and results from mathematical models of vaccine-preventable diseases used, or not, by global health organisations? |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422320/ https://www.ncbi.nlm.nih.gov/pubmed/34489331 http://dx.doi.org/10.1136/bmjgh-2021-006827 |
work_keys_str_mv | AT christenpaula howaremathematicalmodelsandresultsfrommathematicalmodelsofvaccinepreventablediseasesusedornotbyglobalhealthorganisations AT contehlesong howaremathematicalmodelsandresultsfrommathematicalmodelsofvaccinepreventablediseasesusedornotbyglobalhealthorganisations |